Latest Cipla Medpro South Africa News
Feb 11, 2020
Cipla share price rises on distribution agreement for antipsychotic drug The transaction allows Cipla Medpro to market and distribute the Medicine in South Africa and neighbouring countries. × Cipla share price rose over 1 percent after the company's subsidiary entered into an agreement for an antipsychotic drug. Cipla Medpro South Africa (Pty), a wholly-owned subsidiary of Cipla and South Africa’s third-largest pharmaceutical company in the private sector, has recently concluded an exclusive agreement securing originator and authorised generic brands of an atypical antipsychotic drug, Quetiapine. The agreement involves AstraZeneca Pharmaceuticals (Pty), the originator of the Quetiapine, and Luye Pharma Hong Kong, which acquired the assets and rights to the medicine in select territories.